Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Anesthesiology

• Publication date

  1990-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000542-199004000-00007PMID 2321777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group.

  1990cited by this paper
• Standardization of the Caffeine Halothane Muscle Contracture Test

  1989cited by this paper
• Malignant hyperthermia revisited.

  1988cited by this paper
• Malignant hyperthermia. Dantrolene--dynamics and kinetics.

  1988cited by this paper
• In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane‐caffeine, potassium chloride, suxamethonium and caffeine‐suxamethonium

  1987cited by this paper
• Trismus is not trivial.

  1987cited by this paper
• In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.

  1985cited by this paper
• In Vitro Contracture Tests for Susceptibility to Malignant Hyperthermia

  1983cited by this paper
• Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized.

  1979cited by this paper
• Porcine Malignant Hyperthermia Induced by Halothane and Succinylcholine: Failure of Treatment with Procaine or Procainamide

  1976cited by this paper
• Metabolic error of muscle metabolism after recovery from malignant hyperthermia.

  1970cited by this paper

• Malignant Hyperthermia Susceptibility and Related Diseases.

  2018cites this paper
• Administration of Anaesthetic Triggering Agents to Patients Tested Malignant Hyperthermia Normal and Their Relatives in New Zealand: An Update

  2017cites this paper
• Safety of Exposure of Malignant Hyperthermia Non-Susceptible Patients and Their Relatives to Anaesthetic Triggering Agents

  2011cites this paper
• Scientific advances in the genetic understanding and diagnosis of malignant hyperthermia.

  2009cites this paper
• Identification of A Novel Mutation in RYR1 Gene in Malignant Hyperthermia-Like Patient's Family Members

  2008cites this paper
• Follow‐up of patients tested for malignant hyperthermia susceptibility

  2006influential citation
• Malignant hyperthermia and myotonic disorders.

  2002cites this paper
• Disorders of Thermoregulation

  2001cites this paper
• Comparison between the European and North American protocols for diagnosis of malignant hyperthermia susceptibility in humans.

  1999cites this paper
• Malignant hyperthermia and central core disease: disorders of Ca2+ release channels.

  1998cites this paper
• Malignant hyperthermia and central core disease: disorders of Ca2+ release channels.

  1998cites this paper
• Malignant hyperthermia.

  1998cites this paper
• Bayesian Modeling of Muscle Biopsy Contracture Testing for Malignant Hyperthermia Susceptibility

  1998cites this paper
• Bayesian modeling of muscle biopsy contracture testing for malignant hyperthermia susceptibility.

  1998cites this paper
• In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low‐risk subjects

  1997cites this paper
• In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects

  1997cites this paper
• How controversial are anesthetic controversies?

  1997cites this paper
• The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.

  1997cites this paper
• Investigation of malignant hyperthermia susceptibility in Denmark.

  1996cites this paper
• Diagnosis of malignant hyperthermia: a comparison of the in vitro contracture test with the molecular genetic diagnosis in a large pedigree.

  1996cites this paper
• Hyperthermie maligne

  1996cites this paper
• Evaluation of anaesthesias in malignant hyperthermia negative patients

  1995cites this paper
• Clinical effects of intravenously administered dantrolene.

  1995cites this paper
• Masseter Muscle Rigidity and Malignant Hyperthermia Susceptibility in Pediatric Patients An Update on Management and Diagnosis

  1994cites this paper
• Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility?

  1993cites this paper
• Anterior mediastinal mass in a patient susceptible to malignant hyperthermia

  1993cites this paper
• Malignant hyperthermia: halothane- and calcium-induced calcium release in skeletal muscle.

  1993cites this paper
• Acute intraoperative hyperthermic episode: A case report

  1993cites this paper
• Advances in Pediatric Anesthesia: Implications for Otolaryngology

  1992cites this paper
• Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia.

  1992cites this paper
• Malignant hyperthermia: normal muscle calcium uptake and abnormal caffeine and halothane contractures.

  1991cites this paper
• Perioperative complications of anesthesia.

  1991cites this paper
• A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia.

  1991cites this paper
• Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia

  1991cites this paper
• Maligne Hyperthermie heute

  1991cites this paper
• Molecular genetics and malignant hyperthermia.

  1991cites this paper
• Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.

  1990cites this paper